Yehiel Tal
CIK: 0001971982
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLGN
CollPlant Biotechnologies Ltd
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tal Yehiel
Tal Yehiel (SEC CIK 0001971982) files insider reports with the SEC as Chief Executive Officer of CollPlant Biotechnologies Ltd (CLGN).
Signal8 holds 1 ownership filing by Tal Yehiel, a Form 3, filed on Mar 19, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tal Yehiel's filings is in REHOVOT.
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Lask Alisa, Director
- Penn Elan, Director